Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Evolocumab and Clinical Outcomes in Patients with Cardiovascular DiseaseThe New England journal of medicine, 2017-05, Vol.376 (18), p.1713-1722 [Peer Reviewed Journal]Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;info:eu-repo/semantics/openAccess ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1615664 ;PMID: 28304224Full text available |
|
2 |
Material Type: Article
|
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trialThe Lancet (British edition), 2017-04, Vol.389 (10077), p.1399-1409 [Peer Reviewed Journal]Elsevier Ltd ;2017 Elsevier Ltd ;Copyright © 2017 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Apr 8, 2017 ;2017. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(17)30069-7 ;PMID: 28237263Full text available |
|
3 |
Material Type: Article
|
Gigantism and Acromegaly Due to Xq26 Microduplications and GPR101 MutationThe New England journal of medicine, 2014-12, Vol.371 (25), p.2363-2374 [Peer Reviewed Journal]Copyright © 2014 Massachusetts Medical Society. All rights reserved. ;Copyright © 2014 Massachusetts Medical Society. 2014 ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1408028 ;PMID: 25470569Full text available |
|
4 |
Material Type: Article
|
Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 DiabetesThe New England journal of medicine, 2011-03, Vol.364 (10), p.907-917 [Peer Reviewed Journal]Copyright © 2011 Massachusetts Medical Society. All rights reserved. ;2015 INIST-CNRS ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1007994 ;PMID: 21388309 ;CODEN: NEJMAGFull text available |
|
5 |
Material Type: Article
|
Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese SubjectsThe New England journal of medicine, 2010-09, Vol.363 (10), p.905-917 [Peer Reviewed Journal]Copyright © 2010 Massachusetts Medical Society. All rights reserved. ;2015 INIST-CNRS ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1003114 ;PMID: 20818901 ;CODEN: NEJMAGFull text available |
|
6 |
Material Type: Article
|
Effect of Valsartan on the Incidence of Diabetes and Cardiovascular EventsThe New England journal of medicine, 2010-04, Vol.362 (16), p.1477-1490 [Peer Reviewed Journal]Copyright © 2010 Massachusetts Medical Society. All rights reserved. ;2010 Massachusetts Medical Society ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1001121 ;PMID: 20228403 ;CODEN: NEJMAGFull text available |
|
7 |
Material Type: Article
|
Effect of Nateglinide on the Incidence of Diabetes and Cardiovascular EventsThe New England journal of medicine, 2010-04, Vol.362 (16), p.1463-1476 [Peer Reviewed Journal]Copyright © 2010 Massachusetts Medical Society. All rights reserved. ;2010 Massachusetts Medical Society ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1001122 ;PMID: 20228402 ;CODEN: NEJMAGFull text available |
|
8 |
Material Type: Article
|
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trialThe Lancet (British edition), 2005-10, Vol.366 (9493), p.1279-1289 [Peer Reviewed Journal]2005 Elsevier Ltd ;Copyright Lancet Ltd. Oct 8-Oct 14, 2005 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(05)67528-9 ;PMID: 16214598 ;CODEN: LANCAOFull text available |
|
9 |
Material Type: Article
|
Physical activity enhances the improvement of body mass index and metabolism by inulin: a multicenter randomized placebo-controlled trial performed in obese individualsBMC medicine, 2022-03, Vol.20 (1), p.110-110, Article 110 [Peer Reviewed Journal]2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;The Author(s) 2022 ;ISSN: 1741-7015 ;EISSN: 1741-7015 ;DOI: 10.1186/s12916-022-02299-z ;PMID: 35351144Full text available |
|
10 |
Material Type: Article
|
Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled studyThe Lancet (British edition), 2006-11, Vol.368 (9548), p.1660-1672 [Peer Reviewed Journal]2006 Elsevier Ltd ;Copyright Lancet Ltd. Nov 11-Nov 17, 2006 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(06)69571-8 ;PMID: 17098084 ;CODEN: LANCAOFull text available |
|
11 |
Material Type: Article
|
Safety, efficacy and clinical generalization of the STAR protocol: a retrospective analysisAnnals of intensive care, 2016-03, Vol.6 (1), p.24-24, Article 24 [Peer Reviewed Journal]Stewart et al. 2016 ;Annals of Intensive Care is a copyright of Springer, 2016. ;ISSN: 2110-5820 ;EISSN: 2110-5820 ;DOI: 10.1186/s13613-016-0125-9 ;PMID: 27025951Full text available |
|
12 |
Material Type: Article
|
Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe studyThe Lancet (British edition), 2005-04, Vol.365 (9468), p.1389-1397 [Peer Reviewed Journal]2005 Elsevier Ltd ;Copyright Lancet Ltd. Apr 16-Apr 22, 2005 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(05)66374-X ;PMID: 15836887 ;CODEN: LANCAOFull text available |
|
13 |
Material Type: Article
|
Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trialThe Lancet (British edition), 2010, Vol.376 (9740), p.517-523 [Peer Reviewed Journal]Elsevier Ltd ;2010 Elsevier Ltd ;2015 INIST-CNRS ;Copyright 2010 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Aug 14-Aug 20, 2010 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(10)60935-X ;PMID: 20709233 ;CODEN: LANCAOFull text available |
|
14 |
Material Type: Article
|
Insulin sensitivity in critically ill patients: are women more insulin resistant?Annals of intensive care, 2021-01, Vol.11 (1), p.12-12, Article 12 [Peer Reviewed Journal]The Author(s) 2021 ;COPYRIGHT 2021 Springer ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2110-5820 ;EISSN: 2110-5820 ;DOI: 10.1186/s13613-021-00807-7 ;PMID: 33475909Full text available |
|
15 |
Material Type: Article
|
Neurofibromatosis Type 1 Has a Wide Spectrum of Growth Hormone ExcessJournal of clinical medicine, 2022-04, Vol.11 (8), p.2168 [Peer Reviewed Journal]2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 2077-0383 ;EISSN: 2077-0383 ;DOI: 10.3390/jcm11082168 ;PMID: 35456261Full text available |
|
16 |
Material Type: Article
|
The Role of MCM9 in the Etiology of Sertoli Cell-Only Syndrome and Premature Ovarian InsufficiencyJournal of clinical medicine, 2023-01, Vol.12 (3), p.990 [Peer Reviewed Journal]2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 by the authors. 2023 ;ISSN: 2077-0383 ;EISSN: 2077-0383 ;DOI: 10.3390/jcm12030990 ;PMID: 36769638Full text available |
|
17 |
Material Type: Article
|
Inflammatory markers and cardiometabolic diseasesActa clinica belgica (English ed. Online), 2015-06, Vol.70 (3), p.193-199 [Peer Reviewed Journal]Acta Clinica Belgica 2015 2015 ;Copyright Maney Publishing 2015 ;ISSN: 1784-3286 ;ISSN: 2295-3337 ;EISSN: 2295-3337 ;DOI: 10.1179/2295333715Y.0000000004 ;PMID: 26103538Full text available |
|
18 |
Material Type: Article
|
Pituitary Disease in AIP Mutation-Positive Familial Isolated Pituitary Adenoma (FIPA): A Kindred-Based OverviewJournal of clinical medicine, 2020-06, Vol.9 (6), p.2003 [Peer Reviewed Journal]2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 by the authors. 2020 ;ISSN: 2077-0383 ;EISSN: 2077-0383 ;DOI: 10.3390/jcm9062003 ;PMID: 32604740Full text available |
|
19 |
Material Type: Article
|
Gliptin versus a sulphonylurea as add-on to metforminThe Lancet (British edition), 2012-08, Vol.380 (9840), p.450-452 [Peer Reviewed Journal]Elsevier Ltd ;2012 Elsevier Ltd ;Copyright Elsevier Limited Aug 4-Aug 10, 2012 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(12)60859-9 ;PMID: 22748818 ;CODEN: LANCAOFull text available |
|
20 |
Material Type: Article
|
Which incretin-based therapy for type 2 diabetes?The Lancet (British edition), 2014-10, Vol.384 (9951), p.1325-1327 [Peer Reviewed Journal]Elsevier Ltd ;2014 Elsevier Ltd ;Copyright Elsevier Limited Oct 11, 2014 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(14)61097-7 ;PMID: 25018117 ;CODEN: LANCAOFull text available |